News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘ProstateCancer’ clear

  • New research from the Dana-Farber/Brigham and Women's Cancer Center shows that newer, more expensive treatment options for prostate cancer were adopted rapidly and widely during 2002–2005 without proof of their cost-effectiveness.

Tags: ProstateCancer

  • Dana-Farber researchers find many men with low-risk, localized prostate cancers can safely choose observation instead of undergoing immediate treatment and have a better quality of life while reducing health care costs.

Tags: ProstateCancer, PopulationScience

  • Hormone-blocking therapy for prostate cancer doesn’t raise the risk of fatal heart attacks - as some recent studies had suggested - according to a new report from Dana-Farber/Brigham and Women’s Cancer Center.

Tags: Hormones, ProstateCancer

  • Dr. Philip Kantoff says the United States Preventive Services Task Force's conclusion that prostate-specific antigen (PSA) testing provides limited value is the wrong message.

Tags: ProstateCancer

  • A new blood test increases the accuracy of prostate cancer diagnosis and could eliminate tens of thousands of unneeded prostate biopsies annually, Dana-Farber researchers report.

Tags: BasicResearch, ProstateCancer

  • Dana-Farber researchers have demonstrated that a hormone-depleting drug can help eliminate or nearly eliminate aggressive prostate cancers that have yet to spread beyond the prostate.

Tags: Hormones, ProstateCancer, TranslationalResearch

  • Dana-Farber researchers and colleagues report that men with newly diagnosed metastatic, hormone-sensitive prostate cancer lived more than a year longer when they received a chemotherapy drug as initial treatment instead of waiting for the disease to become resistant to hormone-blockers.

Tags: ProstateCancer

  • Prostate tumors that carry a "signature" of four molecular markers have the potential to become dangerously metastatic if not treated aggressively, Dana-Farber Cancer Institute researchers report in an online study published by the journal Nature.

Tags: ProstateCancer, Genetics

  • Practice-changing clinical research conducted at the Dana-Farber Cancer Institute Department of Biostatistics and Computational Biology was featured at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting Plenary Session.

Tags: BreastCancer, ProstateCancer

  • The FDA's approval of Provenge®, a prostate cancer vaccine, marks a new era of using patients' immune systems to treat cancer.

Tags: ImmuneSystem, ProstateCancer, TranslationalResearch, Immunotherapy

Showing 11-20 of 21 items